Elevance Health, Inc. (ELV) Financials
Key financial figures for Elevance Health, Inc. (Q3 2026).
Elevance Q3 2026 adjusted EPS of $6.99 (+15.9% YoY) on $50.4B operating revenue, with FY 2026 adjusted EPS guidance raised to at least $29.00 from at least $27.00. Operating revenue was $50,440M, up 0.7% from $50,087M, on higher premium yields, CarelonRx product revenue and service fees, partly offset by lower Medicare Advantage, Medicaid and Employer Group risk membership. The company said results came in ahead of expectations. GAAP diluted EPS was $6.27 (vs $5.32) and adjusted diluted EPS was $6.99 (vs $6.03). The release cites a net non-operating benefit of $1.85 per share in the quarter; net investment income was $1,037M vs $625M a year earlier. On the outlook: FY 2026 diluted EPS guidance raised to at least $22.00 (from at least $20.10) and adjusted diluted EPS to at least $29.00 (from at least $27.00); FY 2026 operating cash flow raised to at least $6.5 billion (from at least $6.0 billion); the company states a 2026 earnings baseline of at least $26.75 that excludes non-recurring net investment income and other non-operating items, and expects at least 12% adjusted diluted EPS growth in 2027 from that baseline. Figures are for Q3 2026, as Elevance Health, Inc. reported them.
- Revenue
- $51.4B
- Net Income
- $1.4B
- EPS
- $6.30
- Total Assets
- $127.8B
- Operating Cash Flow
- $1.3B
Recent quarters
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| Q3 FY2026 | $51.4B | $1.4B | $6.27 | $1.0B | |
| Q2 FY2026 | $50.5B | $1.5B | $6.71 | $1.6B | |
| Q1 FY2026 | $50.2B | $1.8B | $8.00 | $4.1B | |
| Q4 FY2025 | $49.7B | $547M | $2.47 | -$209M | |
| Q3 FY2025 | $50.7B | $1.2B | $5.32 | $775M |
Recent fiscal years
| Period | Revenue | Net Income | EPS | Operating Margin | Free Cash Flow |
|---|---|---|---|---|---|
| FY2025 | $199.1B | $5.7B | $25.21 | $3.2B | |
| FY2024 | $176.8B | $6.0B | $25.68 | $4.6B | |
| FY2023 | $171.3B | $6.0B | $25.22 | $6.8B |
Frequently asked questions
What was Elevance Health, Inc.'s revenue last quarter?
Elevance Health, Inc. reported revenue of $51.43 billion for Q3 FY2026, up 1.4% from the same period a year earlier.
Is Elevance Health, Inc. profitable?
Yes. Elevance Health, Inc. reported net income of $1.37 billion for Q3 FY2026, a net margin of 2.65% on revenue.
How much free cash flow did Elevance Health, Inc. generate?
Elevance Health, Inc. generated free cash flow of $1.00 billion in Q3 FY2026, after capital expenditure.
Full income statement, balance sheet and cash flow for Elevance Health, Inc. on SentiSense, with up to forty quarters and twenty fiscal years of history.